$8.34
-0.02-0.24%
Last update: Dec 15, 11:31 AM
Comments
Loading...
Day One Biopharmaceutical Earnings Estimates, EPS & Revenue | NASDAQ:DAWN | Benzinga
Day One Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 24
EPS Estimate
$-0.190
Quarterly Revenue Estimate
$43.76M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$133.67M
Analyze the earnings history of Day One Biopharmaceutical using advanced sorting and filters.
Day One Biopharmaceutical (DAWN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $-0.19 | $-0.28 | 32.1 % |
| Q2 | 2025-08-05 | $-0.29 | $-0.35 | 17.1 % |
| Q1 | 2025-05-06 | $-0.35 | $-0.44 | 20.4 % |
| Q4 | 2025-02-25 | $-0.69 | $-0.35 | -97.1 % |
Day One Biopharmaceutical (DAWN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $39.80M | $37.75M | 5.41 % |
| Q2 | 2025-08-05 | $33.91M | $34.82M | -2.62 % |
| Q1 | 2025-05-06 | $30.76M | $30.27M | 1.62 % |
| Q4 | 2025-02-25 | $29.21M | $27.79M | 5.10 % |
FAQ
When is Day One Biopharmaceutical (NASDAQ:DAWN) reporting earnings?
Day One Biopharmaceutical (DAWN) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
What were the latest earnings per share (EPS) for Day One Biopharmaceutical (NASDAQ:DAWN)?
The Actual EPS was $-0.19, which beat the estimate of $-0.28.
What were Day One Biopharmaceutical’s (NASDAQ:DAWN) revenues?
The Actual Revenue was $39.8M, which beat the estimate of $37.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
